MGrx dry eye treatment device
Dry Eye. Solved.

Effective. Affordable. Efficient.

The next generation in dry eye treatment.
FDA Registered
Clinically Validated
30,000 Patients Treated
30-Day Satisfaction Guarantee

Designed Around How You Practice

Every aspect of the MGrx was engineered for the busy eye care provider.
MGrx clinical results: 51% OSDI improvement, 151% TBUT improvement, 30,000+ patients treated
MGrx dry eye treatment video
3 Thermal Treatments - 1 Device
Feature 01

3 Thermal Treatments - 1 Device

The revolutionary MGrx2000 delivers 3 clinically proven treatment with one hand held device. Targeted, controlled pressure and heat combined with the SofGrip Expressor ensures atraumatic, effective meibomian gland expression.

Clinically proven to improve meibomian gland expressibility in 87% of patients after a single in-office session.

Lid Spa - Patient Experience
Feature 02

Lid Spa - Patient Experience

Patients love the MGrx experience. The 5-step Dry Eye Protocol is the most complete and effective dry eye treatment available. The warm thermal massage and gentle expression feel like a spa treatment. Significant relief to dry eye symptoms is typically felt within 24 hours of the treatment. Delivering a delightful, comfortable experience keeps patients coming back and drives word-of-mouth referrals for your practice.

Clinically effective after just one 12-minute in-office session.

Highest ROI, Lowest Cost
Feature 03

Highest ROI, Lowest Cost

Featuring the highest ROI and lowest cost consumable in dry eye, the MGrx stands alone in office efficiency and profitability. Technicians are performing the entire procedure in more than half the clinics that have purchased the MGrx — reducing clinician time to 0! (check your state regulations)

Average treatment time: 12 minutes. Average profit per treatment: $390.

Try it Today.

The trial cost is credited against a purchase
Summer Sale — Limited Time
Summer Sale — 0% financing for 36 months, $445/mo

Purchase Today

$15,995

0% financing for 36 months — just $445/mo

Profitable from Day One

  • 30 day risk-free return
  • Complete MGrx Dry Eye Treatment System
  • Fastest ROI ~40 patients
  • 2 year 'Bumper to Bumper' warranty
  • Just 12 minutes per treatment — can be done by a technician
  • Delight patients after just one treatment
  • 0% financing for 36 months

2-Week Trial

$325one-time

Full device access for 14 days — everything you need to evaluate the MGrx in your practice.

  • Full device access for 14 days
  • Clinical onboarding call with a specialist
  • Dry Eye Protocol Product Bundle for 5 patients ($625 value)
  • Priority support throughout your trial
  • Staff training materials included
  • No long-term commitment required

What Providers Are Saying

Eye care professionals across the country are transforming their dry eye practices with the MGrx.

"The MGrx has completely changed how I approach dry eye in my practice. The treatment outcomes are remarkable, and my patients notice the difference after just one session. It fits perfectly into our workflow."

Dr. Sarah Mitchell

OD, FAAO

Lakeside Vision Center, Portland, OR

"I was skeptical at first, but the clinical data speaks for itself. The real-time reporting feature alone has helped me demonstrate value to patients and justify the treatment. My dry eye revenue has increased significantly."

Dr. James Thornton

OD, Dipl. ABO

Thornton Eye Associates, Austin, TX

"The 2-week trial was all I needed to see the potential. Setup was straightforward, the onboarding team was excellent, and my staff picked it up immediately. We purchased within the first week."

Dr. Priya Nair

OD, FAAO, FSLS

Advanced Eye Care of Chicago

Frequently Asked Questions

Everything you need to know before starting your trial.

The MGrx uses precisely controlled thermal energy combined with gentle mechanical expression to treat meibomian gland dysfunction (MGD), the leading cause of evaporative dry eye. The device applies consistent heat to the eyelid margins to liquefy inspissated meibum, followed by gentle massage to express the glands and restore normal lipid layer function.

The MGrx is indicated for the treatment of meibomian gland dysfunction (MGD) and evaporative dry eye disease. It is appropriate for patients presenting with lid margin telangiectasia, reduced meibomian gland expressibility, decreased tear film lipid layer, and symptoms of chronic dry eye not adequately managed with drops alone.

A complete treatment session takes approximately 12 minutes per patient, including setup and documentation. There is no patient downtime — patients can return to normal activities immediately following treatment. Most patients report noticeable improvement within 24–48 hours of their first session.

Yes. Every 2-week trial includes a dedicated clinical onboarding call with one of our trained specialists, comprehensive staff training materials, and access to our provider support line throughout your trial period. Our team will ensure your practice is fully equipped to deliver treatments confidently from day one.

The $325 trial includes full device access for 14 days and includes the Dry Eye Protocol product bundle to treat 5 patients ($625 value). Product Bundle Includes: 5 SofGrip Expressors 5 Duo USB Compresses 5 Ultra Lid Pro bottles Once the device is received we will schedule a  clinical onboarding call to train you and your staff. If you purchase the device at the end of the trial the trial fee will be applied against the purchase price. If you decide to return the device, the return label is included and there are no additional costs.

You can get started in two ways: purchase the 2-week trial directly for $325 and our team will contact you within one business day to schedule delivery and onboarding, or book a free 10-minute introductory call to speak with a specialist and have any remaining questions answered before committing.

Ready to Transform Your Dry Eye Practice?

Join 500+ eye care providers who have elevated their dry eye outcomes with the MGrx.
No long-term commitment. Cancel anytime.